Objective-The role of receptors for endogenous metabolic danger signals-associated molecular patterns has been characterized recently as bridging innate immune sensory systems for danger signals-associated molecular patterns to initiation of inflammation in bone marrow-derived cells, such as macrophages. However, it remains unknown whether endothelial cells (ECs), the cell type with the largest numbers and the first vessel cell type exposed to circulating danger signals-associated molecular patterns in the blood, can sense hyperlipidemia. This report determined whether caspase-1 plays a role in ECs in sensing hyperlipidemia and promoting EC activation. Approach and Results-Using biochemical, immunologic, pathological, and bone marrow transplantation methods together with the generation of new apoplipoprotein E (ApoE) −/− /caspase-1 −/− double knockout mice, we made the following observations: (1) early hyperlipidemia induced caspase-1 activation in ApoE −/− mouse aorta; (2) caspase-1 −/− /ApoE −/− mice attenuated early atherosclerosis; (3) caspase-1 −/− /ApoE −/− mice had decreased aortic expression of proinflammatory cytokines and attenuated aortic monocyte recruitment; and (4) caspase-1 −/− /ApoE −/− mice had decreased EC activation, including reduced adhesion molecule expression and cytokine secretion. Mechanistically, oxidized lipids activated caspase-1 and promoted pyroptosis in ECs by a reactive oxygen species mechanism. Caspase-1 inhibition resulted in accumulation of sirtuin 1 in the ApoE −/− aorta, and sirtuin 1 inhibited caspase-1 upregulated genes via activator protein-1 pathway. Conclusions-Our results demonstrate for the first time that early hyperlipidemia promotes EC activation before monocyte recruitment via a caspase-1-sirtuin 1-activator protein-1 pathway, which provides an important insight into the development of novel therapeutics for blocking caspase-1 activation as early intervention of metabolic cardiovascular diseases and inflammations. (Arterioscler Thromb Vasc Biol. 2015;35:804-816.
H yperlipidemia, a risk factor for cardiovascular disease, is defined as pathologically elevated plasma concentrations of cholesterol and other lipids, which are commonly found in patients with atherosclerosis. 1 We and others previously reported that hyperlipidemia, proinflammatory mediators, and other risk factors promote endothelial cell (EC) activation and atherosclerosis via several mechanisms, which include inducing endothelial activation and injury, 2,3 increasing monocyte recruitment and differentiation, 4, 5 and decreasing regulatory T cell population. 6, 7 ECs that line the inner surface of vessel wall are the first cells exposed to metabolite-related endogenous danger signals in the circulatory system. 1 Endothelial activation is, therefore, defined as the initial event responsible for monocyte recruitment in atherogenesis. 8 However, questions such as how hyperlipidemia can be sensed by ECs and how hyperlipidemia-induced vascular inflammation is initiated remain largely unanswered.
The cellular receptors, which can recognize the risk factors for atherogenesis, such as hyperlipidemia, have been under intensive search. The role of receptors for pathogenassociated molecular patterns has been characterized recently as bridging innate immune sensory systems for exogenous infectious agents and endogenous metabolic danger signalsassociated molecular patterns (DAMPs) to initiation of inflammation. 9 The toll-like receptors, mainly located in the plasma membrane, recognize a variety of conserved microbial pathogen-associated molecular patterns and metabolic DAMPs and promote inflammatory gene transcription. As we described previously, 10 for inflammation-privileged tissues in which inflammasome component genes are not constitutively expressed, toll-like receptors also work in synergy with cytosolic sensing receptor families, including nod-like receptors (NLRs; NOD [nucleotide binding and oligomerization domain]-like receptors) in recognizing endogenous DAMPs and in mediating upregulation and activation of a range of inflammatory genes. 11 Caspase-1, a member of the cysteine protease family of caspases, is present in the cell cytosol as pro-caspase-1, an inactive zymogen, and requires the assembly of an NLR family member-containing protein complex called inflammasome for activation. Activated caspase-1 is required for cleaving/processing pro-interleukin-1β (IL-1β) and pro-IL-18 into mature proinflammatory cytokines IL-1β and IL-18, respectively, and activation of other inflammatory pathways. However, it remains unclear whether in early atherosclerosis, the caspase-1-inflammasome pathway in ECs can sense elevated lipids as a DAMP and promote endothelial activation.
Previous reports showed that cholesterol crystals activate NLRP3 inflammasome in macrophages, 12, 13 suggesting that NLRP3 inflammasome in macrophages can sense cholesterol crystals formed in advanced stage of atherosclerosis. 14 However, monocyte migration into the aorta after 3 weeks of high fat (HF) diet feeding is detected in atherosclerotic apolipoprotein E (ApoE) −/− mice, 15 suggesting that before cholesterol crystal formation in the vessels, ECs may respond to hyperlipidemia and activate caspase-1 precedent for monocyte recruitment. It has been reported that in response to various proinflammatory stimuli, including lipopolysaccharide, human ECs secrete IL-1β, resulted from the cleavage of pro-IL-1β by activated caspase-1. However, IL-1β secretion from human ECs, detected by ELISA, are 70.6-folds lower than that secreted from human monocytes, 16 suggesting that IL-1β role in ECs as functional consequence of caspase-1 activation may not be as significant as that in monocytes. Thus, additional roles of caspase-1 in ECs need to be further explored. Although proatherogenic functions of caspase-1, 17 NLRP3, 12 IL-1β, 18 and IL-18 19 have been reported, important knowledge gaps remain, such as (1) whether caspase-1 sensing system in ECs can sense early hyperlipidemia (noncholesterol crystals lipid stimulus) and (2) whether caspase-1 activation in ECs can promote endothelial activation, monocyte recruitment, and atherogenesis.
Our previous report showed that caspase-1 can have >70 protein substrates, 20 the list of which is getting longer. A recent report showed that caspase-1 specifically cleaves sirtuin 1 (Sirt1), a nicotinamide adenine dinucleotide-dependent protein/class III histone deacetylase, in adipose tissue during metabolic stress. 21 However, the question of whether caspase-1 cleaves Sirt1 in aortic ECs remains unanswered.
In this study, we examined a novel hypothesis that caspase-1 in ECs can sense hyperlipidemia in mice fed a HF diet for 3 weeks and that caspase-1 activation in ECs, potentially via the caspase-1-Sirt1 pathway, can promote endothelial activation, monocyte recruitment, and atherogenesis. We generated double gene knockout (KO) mice that are deficient of caspase-1 and ApoE (ApoE −/− /caspase-1 −/− ) by crossing caspase-1 −/− mice into ApoE −/− mouse background. Our results demonstrate that caspase-1 activation significantly contributes to endothelial activation, monocyte recruitment, and atherogenesis via the caspase-1-Sirt1-activator protein-1 (AP-1) pathway. Therefore, our results indicate a role for caspase-1 activation in sensing hyperlipidemia as a DAMP and promoting endothelial activation.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Hyperlipidemia Induces the Upregulation of Caspase-1 Expression and Caspase-1 Activation in ApoE −/− Aorta
To examine our hypothesis that early hyperlipidemia activates the caspase-1 11 in the aortic tissue, we performed Western blot analysis with caspase-1 antibodies on mouse aortic protein lysates collected from wild-type (WT) mice and ApoE −/− mice fed a HF diet for 0, 3, and 6 weeks. Plasma lipid profiling data ( Figure 1A ) showed that 3-week HF diet feeding significantly increased plasma cholesterol levels and triglyceride levels in ApoE −/− mice, reaching hyperlipidemic conditions (>200 mg/dL). More importantly, pro-caspase-1 expression levels ( Figure 1B ) were significantly upregulated in ApoE −/− mouse aorta after feeding a HF diet for 3 (122%) and 6 weeks (160%), respectively. Because catalytic activation of procaspase-1 (45 kDa) into 2 smaller subunits, p20 and p10, in a protein complex termed inflammasome is required for its protease activity, we also examined the expression of activated caspase-1 p20 subunit. The results ( Figure 1B ) showed that activated caspase-1 was increased in ApoE −/− mouse aorta fed with a HF diet for 3 weeks (604%) and 6 weeks (818%), respectively. Of note, upregulation of pro-caspase-1 induced by 6 weeks of HF diet feeding in ApoE −/− mouse aorta was ≈2-folds higher than that of WT mouse aorta. In contrast, activated caspase-1 p20 expression in HF diet-fed ApoE −/− mouse aorta was >8 folds higher than that of WT mouse aorta. With the lipid profiling data, we performed regression analysis of the lipid data against expression data of p20-activated caspase-1 detected by Western blot in Figure 1B . We found that Figure 1C ), suggesting that caspase-1 activation is tightly associated with elevated cholesterol and triglycerides levels, as early as 3 weeks of hyperlipidemia. Of note, the expression of pro-caspase-1 in non-HF diet fed ApoE −/− mouse aorta was not significantly higher than that in non-HF diet fed WT mouse aorta, suggesting that upregulation of procaspase-1 in HF diet-fed ApoE −/− mouse aorta was not because of deficiency of the ApoE gene.
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The results showed that hyperlipidemia also upregulated the expression of caspase-1 mRNA ≈2-folds ( Figure 1D ), which was similar to the upregulation of pro-caspase-1 detected by Western blots. These results suggest that upregulation of pro-caspase-1 induced by hyperlipidemia in HF diet-fed ApoE −/− mouse aorta results from the hyperlipidemia-induced transcriptional mechanism and the posttranslational mechanism. As the substrate of activated caspase-1, cleaved and activated IL-1β was induced after 3 weeks of HF diet in the aortas of WT and ApoE −/− mice. In addition, the expression of pro-IL-1β was also induced ( Figure 1E ). Taken together, the results demonstrated that early hyperlipidemia induces the upregulation of caspase-1/IL-1β expression and caspase-1/ IL-1β activation in mouse aorta. Since Dr Ross and his colleagues pointed out that significant monocyte recruitment into ApoE −/− mouse aorta does not happen until 6 weeks after HF diet feeding, 15 our results suggest that caspase-1 is activated in aortic residential cells at the early stage of atherosclerosis.
Deficiency of Caspase-1 in ApoE −/− Background Results in Decreased Atherosclerotic Lesion in the Early Stage of Atherogenesis
To examine the hypothesis that caspase-1 plays an important role in early atherogenesis, ApoE −/− /caspase-1 −/− double gene KO mice were generated. The protein expression of pro-caspase-1 in mouse aorta ( Figure More importantly, after 3 weeks of HF diet, the atherosclerotic lesions in the aortic sinus area, the most sensitive atherogenic area in the aorta, of the double KO mice were significantly decreased by 44% (lesion area mean±2SD=3.92%±1.42%) compared with that of ApoE −/− mice (6.98%±2.67%; P=0.0147; Figure 2A and 2B). The results demonstrated that caspase-1 plays a critical role in promoting early atherogenesis.
Deficiency of Caspase-1 in ApoE −/− Background Results in Decreased Expression of Proinflammatory Cytokines and Chemokines in the Aorta
Because proinflammatory cytokines and chemokines play essential roles in recruiting inflammatory cells into the aorta during atherogenesis, 22 to determine the molecular mechanism underlying the reduction in atherosclerotic lesion formation in ApoE −/− /caspase-1 −/− mice, we examined the hypothesis that the decrease in atherosclerotic lesion may be a result of the decreased generation of proinflammatory cytokines and chemokines in mouse aorta. We used an antibody array to compare simultaneously the expressions of 40 cytokines and chemokines in ApoE −/− /caspase-1 −/− mouse aorta and ApoE −/− mouse aorta ( Figure higher than those in caspase-1 −/− /ApoE −/− mouse aorta. These 17 upregulated cytokines and chemokines included soluble intercellular adhesion molecule-1 (ICAM-1), chemokine (C-C motif) ligand-17 (CCL17), granulocyte-macrophage colony stimulation factor (CSF2), tissue inhibitor of metalloproteinases-1, IL-27, IL-2, CCL1, IL-23, IL-7, IL-10, IL-16, IL-1α, CCL11, CCL2, CCL4, IL-1 receptor antagonist (IL-1ra), and CCL12. Most of these cytokines and chemokines are proinflammatory except tissue inhibitor of metalloproteinases-1, IL-10, and IL-1ra, suggesting that early hyperlipidemia promotes the generation of proinflammatory cytokines and chemokines more than anti-inflammatory cytokines/chemokines, whereas caspase-1 deficiency attenuates the generation of these proinflammatory cytokines and chemokines. It has been reported previously that besides being the converting enzyme for IL-1β and IL-18 maturation, caspase-1 also serves as a regulator for the expression of IL-1α, TNF-α, and IL-6 23 and for the secretion of unconventional proteins. 24 Of note, IL-1β was not detected in ApoE −/− mouse aorta after 3 weeks of HF feeding, suggesting that the cytokine array used here is not sensitive enough to detect the IL-1β differences between the groups. Several proinflammatory cytokines, including IL-4, IL-5, IL-6, and IL-12, were reported to express in mouse plasma samples collected from 10-week-old HF diet fed ApoE −/− mice, 25 which was not evident in our results. This discrepancy may be because our experiments were designed to examine early hyperlipidemia (3 weeks of HF diet feeding)-induced cytokine expression. Taken together, our results suggest that deficiency of caspase-1 results in decreased expression of proinflammatory cytokines and chemokines in the aorta.
Deficiency of Caspase-1 in ApoE −/− Background Results in Decreased Recruitment of Monocytes into the Aorta
Because recruitment of monocytes and other inflammatory cells into the mouse aorta and other arteries is essential for atherogenesis, 1 based on our above results of decreased expression of inflammatory cytokines and chemokines in double KO aorta, we hypothesized that caspase-1 deficiency may result in reduced monocyte recruitment into the mouse aorta. We performed single cell analysis of mouse aortic cells with fluorescence-conjugated antibody staining for F4/80 and CD11b followed by flow cytometric analysis as reported previously. 26, 27 The results ( Figure 3A and 3B) showed that caspase-1 deficiency in ApoE −/− background decreased F4/80 + /CD11b − macrophage recruitment into the aorta, but the reduction did not have statistical significance (P=0.0621). In contrast, the results also showed that caspase-1 deficiency significantly decreased F4/80 + CD11b + monocyte recruitment into the aorta (P=0.0045) and F4/80 − CD11b + monocyte recruitment into the aorta (P=0.0194), respectively. In addition, we further determined whether aortic monocyte composition changes resulted from the changes in the peripheral blood. The results in Figure 3C showed that total mononuclear cells and CD11b + monocytes in ApoE −/− /Caspase-1 −/− mouse blood had no statistical differences to that of ApoE −/− mice. Moreover, we determined whether aortic monocyte composition changes as a result of alterations in the proliferation of recruited monocytes in mouse aorta. Because cell size of cell populations detected by the forward scatter with flow cytometry could be an estimate of cell proliferation status, 28 the results in Figure III in the online-only Data Supplement showed that the 3 cell size fractions (large, middle, and small) in 3 cell subsets, including F4/80 + CD11b − macrophages, F4/80 + CD11b + monocytes, and F4/80 − CD11b + monocytes, in ApoE −/− /Caspase-1 −/− mouse aortas had no statistical differences in comparison to that of ApoE −/− mouse aortas. Taken together, our results demonstrated that first, caspase-1 deficiency in ApoE −/− background decreased the recruitment of monocytes into the mouse aorta in early atherosclerosis; second, caspase-1 deficiency in ApoE −/− background did not significantly decrease F4/80 + CD11b − macrophage recruitment into the aorta in early atherosclerosis, suggesting that caspase-1 deficiency did not result in a defect of monocyte-to-macrophage differentiation in the early atherosclerosis; and third, the aortic data of caspase-1 deficiency in ApoE −/− background was a result of aortic recruitment of monocytes but not as a result of the percentage changes of mononuclear cell and CD11b + monocyte populations in the peripheral blood in early atherosclerosis.
Deficiency of Caspase-1 in ApoE −/− Background Results in Decreased Endothelial Activation, Including Reduced Cell Adhesion Molecule Expression and Attenuated Cytokine and Chemokine Secretion
A significant decrease in the recruitment of monocytes into the mouse aorta without changes in the peripheral blood monocyte compositions leads to our hypothesis that caspase-1 deficiency in early atherosclerosis decreases endothelial activation rather than reducing the potency of monocyte infiltration into the mouse aorta. Endothelial activation can be examined from 2 prospectives. First, we reasoned that decreased endothelial activation would result in decreased secretion of cytokines and chemokines. To examine this possibility, mouse aortic ECs (MAECs) from WT mice and caspase-1 −/− mice were cultured and primed with 50 ng/mL lipopolysaccharide and treated with 200 μg/mL of oxidized low-density lipoprotein (oxLDL; first signals for the inflammasome activation) 10 for 24 hours followed with adenosine-5′-triphosphate (5 mmol/L) spike (second signal for the inflammasome activation) 11 for 20 minutes. The antibody array results ( Figure IV in the onlineonly Data Supplement) showed that caspase-1 deficiency significantly attenuated the secretion of C-X-C motif chemokine 10 (CXCL10), CCL3, CXCL2 (MIP-2) and granulocyte-macrophage colony stimulation factor levels from MAECs. Second, we further reasoned that decreased endothelial activation in caspase-1-deficient mice would result in decreased upregulation of endothelial adhesion molecules, including ICAM-1, vascular cell adhesion molecule (VCAM)-1, and E-selectin. To examine this possibility, we first examined the adhesion molecule expression in aortas from ApoE −/− mice and ApoE −/− /caspase-1 −/− mice. The results ( Figure 4A ) showed that 3 weeks of HF feeding induced upregulation of ICAM-1 (17.8-folds) and VCAM-1 (3.5-fold) protein expressions in ApoE −/− mouse aorta, respectively. On the contrary, HF diet feeding upregulated ICAM-1 and VCAM-1 expressions only by 2-folds and 1.5-folds, respectively, in the ApoE −/− /caspase-1 −/− aorta. Of note, we did not find a difference in E-selectin expression between ApoE −/− and ApoE −/− / caspase −/− aortas. We then used RT-polymerase chain reaction to further examine the mRNA transcripts of ICAM-1, VCAM-1, and E-selectin in MAECs from WT mice and caspase-1 −/− mice stimulated with oxLDL (100 μg/mL). The results ( Figure 4B ) showed that oxLDL stimulation induced mRNA upregulation of ICAM-1, VCAM-1, and E-selectin in WT MAECs by 10-, 8-, and 17-folds, respectively. In contrast, oxLDL stimulation induced no mRNA upregulation of ICAM-1, VCAM-1, and E-selectin in caspase-1 −/− MAECs. The differences between the protein expression of adhesion molecules in mouse aortas and their mRNA expressions in MAECs may be because in addition to ECs, some adhesion molecules are also expressed in other vascular cells, including smooth muscle cells in mouse aorta. 29 Regardless of the differences between the 2 experimental systems, caspase-1 deficiency resulted in decreased induction of EC adhesion molecules ICAM-1 and VCAM-1 in mouse aorta and MAECs in response to hyperlipidemic stimulations. Because attenuation of hyperlipidemia-induced ICAM-1 upregulation by caspase-1 deficiency was most dramatic among adhesion molecules examined, we looked into the possibility that caspase-1 activity-positive ECs may have higher ICAM-1 expression than caspase-1-inactive ECs. The results ( Figure 4C ) showed that ECs with active caspase-1 have higher ICAM-1 expression than caspase-1-inactive ECs, suggesting that caspase-1 activation promotes ICAM-1 upregulation and endothelial activation. Furthermore, we wanted to determine whether caspase-1 activation functionally promotes human aortic ECs (HAECs) to be more adhesive to unstimulated monocytes. Indeed, we found that oxLDL increased adhesiveness of ECs to monocytes ( Figure 4D ), which were inhibited by caspase-1 inhibitors, suggesting that caspase-1 activation increases upregulation of adhesion molecules, promotes endothelial activation, and makes ECs more adhesive to monocytes.
Deficiency of Caspase-1 in the Aorta of ApoE −/− Mice Results in Decreased Recruitment of Transplanted Caspase-1 +/+ Bone Marrow-Derived Inflammatory Ly6C middle/high Monocytes into the Aorta
To further consolidate our finding on the role of caspase-1 in promoting aortic endothelial activation and monocyte recruitment into the aorta, we performed chimeric bone marrow (BM) transplantation with enhanced green fluorescence protein transgenic mouse BM as the donor group and ApoE −/− mice and ApoE −/− /caspase-1 −/− mice as the 2 recipient groups ( Figure 5A and 5B ). We reasoned that if caspase-1 activation promotes endothelial activation and monocyte recruitment, then more caspase-1 activity + enhanced green fluorescence protein + BM-derived Ly6C middle/high inflammatory monocytes should migrate into the ApoE −/− aorta than the ApoE −/− /caspase-1 −/− aorta. Indeed, we found that significantly more GFP + CD11b − Ly6C middle cells and GFP + CD11b + Ly6C high BM-derived monocytes migrated into the ApoE −/− aorta than the ApoE −/− /caspase-1 −/− aorta ( Figure 5C and 5D ; P<0.05).
As control experiments, we examined the peripheral blood monocyte subsets in the 2 recipient mouse groups. In contrast, we did not find any significant difference in peripheral blood monocyte subsets between the 2 recipient groups ( Figure 5E and 5F ). In addition, after caspase-1 +/+ (WT) GFP transgenic BM cell transplantation into either ApoE −/− recipient mice or caspase-1 −/− /ApoE −/− double gene KO recipient mice, caspase-1 −/− /ApoE −/− double gene KO recipient mice had significantly less atherosclerotic lesions than ApoE −/− recipient mice ( Figure 5G ). Although that ECs are not the only vascular residential cells that have caspase-1 activation in response to inflammatory stimuli 30 and that EC-specific role of caspase-1 may ultimately require the model of EC-specific deficient mice of caspase-1, the results correlated well with our previous findings and suggested that caspase-1 activation in aortic ECs promotes monocyte recruitment into the aorta. 
Atherogenic Lipid Products Induce Caspase-1 Activation and Endothelial Inflammation via a Reactive Oxygen Species-Dependent Pathway
Our data demonstrated that caspase-1 plays a critical role in promoting EC activation and monocyte recruitment into the mouse aorta exposed to hyperlipidemia. To further determine whether atherogenic lipid products induce caspase-1 activation in ECs and whether reactive oxygen species (ROS) plays any role in caspase-1 activation in ECs, we used oxLDL and 2 oxLDL derivatives, lysophosphatidic acid (lysoPA), and lysophosphatidylcholine (lysoPC) 31 to stimulate HAECs. Because plasma membrane rupture and caspase-1 activation are 2 key features of the newly characterized inflammatory cell death (pyroptosis), 32 cytometry-based fluorescence-labeled caspase-1 enzymatic activity assay to detect caspase-1 activation, we also used fluorescence dye 7-AAD to measure plasma membrane integrity. We classified caspase-1 enzymatically active (capase-1 + ) and 7AAD − (caspase-1 + /7-AAD − ) cells as inflammatory ECs, caspase-1 + /7-AAD + cells as pyroptotic cells, and caspase-1 − /7-AAD + cells as necrotic cells. We found that oxLDL, lysoPA, and lysoPC induced inflammation, inflammatory cell death (pyroptosis), and necrosis after 6-hour stimulation in HAECs ( Figure 6A ). We then examined whether ROS plays any role in oxidized lipids-induced caspase-1 activation by costaining inflammatory, pyroptotic, and necrotic ECs with ROS probe dihydroethidium. Our results showed that the mean fluorescence intensities of dihydroethidium stain in ruptured cells (either pyroptotic cells or necrotic cells) were higher than that of the inflammatory cells ( Figure 6B ), suggesting that oxidized lipids increased ROS-mediated caspase-1 activation and that cell death requires higher ROS levels to trigger than inflammation. We further verified the results with ROS inhibitors allopurinol (xanthine oxidase inhibitor) and apocynin (NADPH oxidase inhibitor) for inhibition of caspase-1 activation ( Figure 6C ). Finally, we examined whether oxLDL induces upregulated caspase-1 and inflammasome component transcripts in ECs. The RT-polymerase chain reaction results ( Figure 6D ) showed that treatment of oxLDL for 24 hours upregulated significantly NLRP1, NLRP3, caspase-1, PYCARD, and IL-1β transcripts. Because inflammasome assembly for caspase-1 activation requires NLRP, PYCARD, and procaspase-1, and effective upregulation of transcription of inflammasome and caspase-1 occurs ≈24 hours after stimulation, these results suggest that post-translational caspase-1 activation is much earlier than upregulation of caspase-1 and inflammasome transcription in ECs.
Caspase-1 Activation in the Mouse Aorta and Human Aortic Endothelial Cells Decreases the Expression of Anti-Inflammatory Protein/ Histone Deacetylase Sirt1 by Cleaving Sirt1
As we detected only weak active IL-1β expression in the mouse aorta ( Figure 1E HF diet, we hypothesized that the effect of caspase-1 activation on endothelial activation is probably contributed more by other pathways rather than the IL-1β pathway. Thus, we attempted to search for novel substrate of caspase-1 that could modulate inflammation and endothelial activation. Among 24 experimentally verified caspase-1 substrates that we found in a literature search, 20 Sirt1 has recently been suggested to be cleaved by caspase-1. 21 Because Sirt1 has previously been reported to regulate endothelial activation and has antiatherogenic function, 33 we then hypothesized that caspase-1-deficient mouse aorta has accumulation of noncleaved Sirt1. To test this hypothesis, we examined Sirt1 expression by Western blot with Sirt1 antibody in the following 4 groups of mice Figure IC in the online-only Data Supplement) were in the range of 220 to 320 mg/dL, which were a few folds higher than those in WT mice (average 109 mg/dL; Figure 1A ). Our results suggest that caspase-1 activation induced by moderate hyperlipidemia is responsible for cleaving Sirt1 and hyperlipidemia induced by HF feeding further triggers additional uncharacterized proteinase(s) to cleave/degrade Sirt1. Then, we examined whether oxLDL decreases Sirt1 expression in HAECs by caspase-1 cleavage mechanism. The results ( Figure 7B ) showed that oxLDL induced the expression of cleaved-Sirt1 by 2.4-folds in HAECs. To examine whether the induced cleavage form of Sirt1 was the result from the specific enzyme activity of Casp1, we designed a new cell permeable noncleavable Sirt1 (NC-Sirt1) by replacing the aspartate (D) in the amino acid position 150 of human Sirt1 with alanine (A), the specific cleavage site of Sirt1 recognized by Casp1 21 (Figure V in the online-only Data Supplement). Our results showed that NC-Sirt1 dose-dependently decreases the cleavage of Sirt1 induced by oxLDL. In addition, 2 different ROS scavengers (PEG-SOD and PEG-catalase) independently and synergistically inhibit oxLDL-induced, Casp1-mediated Sirt1 cleavage. Furthermore, the proteasome inhibitor MG-132 inhibited oxLDL-induced Sirt1 cleavage, suggesting that the cleaved Sirt1 may be further subjected to a putative proteolysis by an uncharacterized proteasome-controlled proteinase. Thus, when MG-132 inhibits proteasome, the expression of this uncharacterized proteasome-controlled proteinase is increased, which leads to decreased expression of caspase-1 cleaved Sirt1. These results suggest that oxLDL first increases ROS, which promotes caspase-1 activation for cleaving Sirt1. We then used the PeptideCutter database of the Swiss Institute of Bioinformatics to analyze the potential enzymes that can cleave the human Sirt1 protein sequence. The results ( I in the online-only Data Supplement) showed that caspase-1 and caspase-3 are among the enzymes that can cleave Sirt1 and are regulated by ROS, although the predicted cleavage site on Sirt1 for caspase-1 is not the same one as experimentally determined. 21 Taken together, our results suggest that caspase-1 in the mouse aorta and HAECs cleaves Sirt1 protein in response to hyperlipidemic stimuli.
Caspase-1 Activation Induces Expression of Cytokines, Chemokines, and Adhesion Molecules via an Sirt1-AP-1-Mediated Pathway
Our data showed that caspase-1 activation induces the upregulation of several EC activation-associated cytokines, chemokines, and endothelial adhesion molecules. To further explore the mechanism underlying this caspase-1 function, we hypothesized that caspase-1 activation leads to a Sirt1-controlled transcription factor pathway to regulate these genes. Among the transcription factors that are modulated by Sirt1 are AP-1 34 and NF-κB. 35 We examined whether lysoPC-activated AP-1 activity and NF-κB activity can be inhibited by caspase-1 inhibitors by performing electrophoretic mobility shift assay. The results ( Figure 7C ) showed that lysoPC-induced AP-1 binding to AP-1 consensus nucleotides were inhibited by caspase-1 inhibitor, whereas lysoPC-activated NF-κB binding to NF-κB consensus probe was not significantly affected by caspase-1 inhibitors. We then searched for published experimental evidence that caspase-1-induced cytokines, chemokines, and adhesion molecules (Figures II and IV in the onlineonly Data Supplement; Figure 4) ) are AP-1 targeted genes.
The results (Table IIA in the online-only Data Supplement) showed that 11 out of 14 caspase-1-induced genes are experimentally verified AP-1 pathway-induced genes.
In addition, analysis from the microarray experimental results of Sirt1 gene-deficient mice in comparison to WT mice showed that the expression of these AP-1-targeted genes are increased in Sirt1-deficient mice ( Table IIA in the online-only Data Supplement), suggesting that Sirt1 inhibits the expression of AP-1 targets. Moreover, the data-mining results ( Table IIB in the online-only Data Supplement) showed that the expressions of AP-1 genes themselves, including Jun and Fos, are increased in Sirt1-deficient mice. Taken together, the results suggest that caspase-1-cleavable Sirt1 inhibits the expression of caspase-1-induced cytokines, chemokines, and adhesion molecules by suppressing AP-1 gene transcription and AP-1targeted gene transcription, which further suggest that caspase-1 induces the expression of cytokines, chemokines, and adhesion molecules in ECs by cleavage and inhibition of Sirt1.
Discussion
Although the role of caspase-1 in atherogenesis remains controversial, 36 the prevailing concept is that caspase-1 plays a proatherogenic role, which is supported by results collected from ApoE −/− /caspase-1 −/− mice, 17, 37 inflammasome sensor NLRP3 KO BM cells in LDL receptor (LDLR) −/− mice, 12 ApoE −/− / IL-1β −/− mice, 38 and ApoE −/− /IL-18 −/− mice. 39 Of note, Gage et al 17 and Usui et al 37 studied the role of caspase-1 deficiency in full-blown atherosclerosis in ApoE −/− mice after HF feeding for 8 weeks 17 and 12 weeks. 37 In addition, it has been reported that NLRP3 mediates hemodynamic-induced EC activation 40 and that the IL-1β mRNA/protein as well as NLRP3 mRNA are upregulated in 30 week HF feeding-induced atherosclerotic lesion and endothelium of diabetic pigs. 41 Along the line, we further asked whether in the early atherogenesis associated with early hyperlipidemia induced by only 3 week HF feeding, caspase-1 activation, as metabolic stress-related danger signal-associated molecular pattern-sensing pathway, 11 could be involved in endothelial activation. Using biochemical, immunologic, and pathological approaches and our newly generated ApoE −/− /caspase-1 −/− mice, we addressed this question and have the following results: (1) early hyperlipidemia induces the upregulation of caspase-1 expression and caspase-1 activation in ApoE −/− aorta, which supports our previously proposed 3-tier/inflammation privilege model for determining tissue readiness to caspase-1 activation and inflammation initiation 10 ; (2) caspase-1 deficiency in ApoE −/− background results in decreased early atherosclerotic lesion formation, suggesting that caspase-1 activation in ECs promotes early atherogenesis; and (3) caspase-1 deficiency in ApoE −/− background results in decreased expression of proinflammatory cytokines and chemokines in the aorta. Of note, the expression of 2 anti-inflammatory cytokines IL-10 and IL-1ra were also decreased in caspase-1-deficient aorta. However, the decreased expressions of as many as 15 proinflammatory cytokines in caspase-1-deficient aorta outweigh concomitant reduction of 2 anti-inflammatory cytokines, suggesting that caspase-1 activation promotes an inflammatory environment and a chemokine gradient more than anti-inflammatory environment for the recruitment of monocytes and other inflammatory cells into the aorta; (4) caspase-1 deficiency in ApoE −/− background results in decreased recruitment of monocytes into the aorta but has no significant role in monocyte composition in the peripheral blood in the early stage of atherosclerosis, suggesting that caspase-1 activation promotes monocyte recruitment into the aorta presumably via promoting endothelial activation and not via increasing monocyte compositions in the peripheral blood; (5) caspase-1 deficiency in ApoE −/− background results in decreased endothelial activation, including reduced cell adhesion molecule expression and attenuated cytokine and chemokine secretion, suggesting that increased caspase-1 activities promote endothelial activation; (6) caspase-1 deficiency in ApoE −/− mice results in decreased recruitment of transplanted caspase-1 + BM-derived inflammatory Ly6C middle/high monocytes into the caspase-1 −/− aorta, suggesting that caspase-1 activation can lead to endothelial activation, which subsequently recruits more monocyte into the aorta. Decreased recruitment of caspase-1 + BM-derived inflammatory Ly6C middle/high monocytes into the caspase-1 −/− aorta results in less atherosclerosis than caspase-1 +/+ aorta. To further determine the underlying molecular signaling mechanisms, we found (7) atherogenic lipid products induce caspase-1 activation and endothelial inflammation via a ROS-dependent pathway; (8) caspase-1 deficiency in ApoE −/− /caspase-1 −/− aorta and inhibition of caspase-1 in ECs result in accumulation of anti-inflammatory protein/histone deacetylase Sirt1, which is a substrate of caspase-1, suggesting that caspase-1 activation in early atherogenesis promotes endothelial activation via a Sirt1 pathway; and (9) caspase-1 activation induces the upregulation of cytokines, chemokines, and adhesion molecules in ECs via a Sirt1-AP-1-mediated pathway.
Although our previous report showed that caspase-1 can cleave numerous protein substrates, 20 it is generally considered that caspase-1 fulfills its proinflammatory functions predominately by cleaving pro-IL-1β and pro-IL-18 into mature IL-1β and IL-18, respectively. Although the role of proinflammatory cytokines IL-1β 38 and IL-18 39 , as the classical substrates of caspase-1, in the promotion of atherosclerosis has been reported, the role of caspase-1, IL-1β, and IL-18 in promoting EC activation in the early stage of atherogenesis remained unknown. As defined by Ross' laboratory in ApoE −/− mice, 15 early atherosclerosis is the initiative stage precedent the occurrence of a large number of monocyte recruitment before 6 weeks of HF feeding in ApoE −/− mice. Our results were well correlated with a previous report that IL-1β secretion from human ECs are 70.6-folds lower than that secreted from human monocytes, 16 suggesting that IL-1β role in ECs may not be as significant as that in monocytes. These results indicate that caspase-1 may not only act through an IL-1β-or IL-18-dependent pathway to promote endothelial activation. Instead, we found that caspase-1 activation in mouse aorta in early atherogenesis and in human aortic ECs stimulated by oxLDL promotes endothelial activation via a Sirt1-inhibitable pathway. It was reported that Sirt1 reduces endothelial activation, 42 and overexpression of Sirt1 in ECs inhibits atherosclerosis. 33 Mechanistically, adenovirus-mediated overexpression of Sirt1 significantly inhibits PMA (phorbol 12-myristate 13-acetate)/ionomycin-induced ICAM-1 expression in human umbilical vein ECs, whereas knockdown of Sirt1 by RNA interference results in increased expression of ICAM-1 and increases NF-κB p65 binding ability to the ICAM-1 promoter by ChIP assays in human umbilical vein endothelial cells. 43 However, the issue of whether caspase-1 in aortic ECs senses hyperlipidemia to initiate vascular inflammation via inhibiting Sirt1 was not examined until this report. Taken together, our results demonstrate a novel mechanism in early atherosclerosis: caspase-1 promotes EC activation and monocyte recruitment via decreasing Sirt1 expression and activating AP-1 pathway. The novel caspase-1-Sirt1-AP-1 pathway and the classical caspase-1-IL-1β-IL-18 are not mutually exclusive. HF diet feeding for >6 weeks promoted monocyte recruitment into the aorta, 15 thus, the classical caspase-1-IL-1β and Il-18 pathway in recruited monocytes and macrophages may interplay with caspase-1-Sirt1-AP-1 pathway in ECs during later stages of atherosclerosis.
Endothelial activation is the first and essential step for atherogenesis, which includes 2 molecular events-upregulation of cell surface adhesion molecules to make ECs more adhesive and increased secretion of proinflammatory cytokines and chemokines to attract monocytes and other inflammatory cells for transendothelial recruitment. 9 Monocytes and macrophages play an essential role in promoting atherogenesis; however, we reason that if ECs are not activated during the initiation of atherogenesis, then no monocytes in the peripheral blood can be recruited into the aorta. Our results showed that caspase-1 deficiency did not alter the composition of peripheral blood monocytes and macrophages in early hyperlipidemia but instead significantly decreased aortic monocyte recruitment, suggesting that caspase-1-deficient ECs are less activated for recruitment of monocytes into the aorta. These findings were further supported by our BM transplantation results, as well as the decreased ICAM-1 and VCAM-1 and proinflammatory cytokine and chemokine expressions/secretion in HAECs and in caspase-1-deficient mouse aorta. A recent report showed that suppression of monocyte recruitment results in removal of macrophage from atherosclerotic plaques of ApoE −/− mice, 44 which echoes the importance of our finding. It has been reported that chemokine CXCL16 and its receptor CXCR6 play a critical role in mediating T cell migration into aorta during atherogenesis. 45 To determine whether CXCL16 and CXCR6 expressions are regulated by caspase-1 pathway, we searched extensively the National Institute of Health-GeoProfile microarray database and found that both CXCL16 and its receptor CXCR6 expressions are downregulated in caspase-1 KO mice microarray in comparison to that in WT control microarray (Geo-data set GDS3925), suggesting that casapse-1 activation promotes CXCL16 and CXCR6 expression and presumably T cell migration into aorta during atherogenesis. Thus, T cell migration into caspase-1 −/− /ApoE −/− mouse aortas may be decreased.
In our newly proposed working model, we summarize our findings and highlight current understanding ( Figure 8 ): (1) hyperlipidemia induces elevation of ROS via NADPH oxidase-dependent pathway; (2) increased ROS levels induce caspase-1 activation, EC inflammation, and endothelial pyroptosis (inflammatory cell death); (3) activated caspase-1 decreases anti-inflammatory protein/histone deacetylase Sirt1 expression by cleaving Sirt1; (4) Sirt1 is a high hierarchy gene that can deacetylate and inhibit proinflammatory transcription factors, including AP-1; and (5) the caspase-1-Sirt1-AP-1 pathway can promote endothelial activation, inflammation, and atherogenesis. Our results have demonstrated for the first time how hyperlipidemia, one of the most important metabolic risk factors, induces endothelial activation, which provides an important insight for future development of novel therapeutics for early intervention of cardiovascular diseases and other inflammatory diseases.
